These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 35793691

  • 21. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 22. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
    Pamukcu B, Lane DA, Lip GY.
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF, Ganetsky V, Spinler SA.
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [Abstract] [Full Text] [Related]

  • 25. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
    Lip GYH, Lane DA, Buller H, Apostolakis S.
    Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds.
    Dimitropoulos G, Rahim SMZ, Moss AS, Lip GYH.
    Expert Opin Investig Drugs; 2018 Jan; 27(1):71-86. PubMed ID: 29224364
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L.
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [Abstract] [Full Text] [Related]

  • 33. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C, Vedovati MC, Agnelli G.
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [Abstract] [Full Text] [Related]

  • 34. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L.
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].
    Gulizia Chairperson MM, Parrini Co-Chairperson I, Colivicchi Co-Chairperson F, Bisceglia I, Caiazza F, Gensini GF, Mureddu GF, Santomauro M, Ageno W, Ambrosetti M, Aspromonte N, Barni S, Bellocci F, Caldarola P, Carletti M, De Luca L, Di Fusco SA, Di Lenarda A, Di Nisio M, Domenicucci S, Enea I, Francese GM, Lestuzzi C, Lucà F, Maurea N, Nassiacos D, Pedretti RFE, Pusineri E, Roscio G, Rossini R, Russo A, Volterrani M, Gabrielli Co-Chairperson D.
    G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.
    Am J Cardiol; 2017 May 15; 119(10):1590-1595. PubMed ID: 28363354
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
    Hughes M, Lip GY, Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence.
    Thromb Haemost; 2008 Feb 15; 99(2):295-304. PubMed ID: 18278178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.